---
category: news
title: "BioXcel Therapeutics Announces Promising Top-Line Results from Phase 2 Trial of BXCL701 in Aggressive Form of Rare Prostate Cancer"
excerpt: "BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology, today announced promising top-line data from its Phase 2 trial of BXCL701,"
publishedDateTime: 2023-01-11T13:43:00Z
originalUrl: "https://www.tmcnet.com/usubmit/-bioxcel-therapeutics-announces-promising-top-line-results-from-/2023/01/11/9741357.htm"
webUrl: "https://www.tmcnet.com/usubmit/-bioxcel-therapeutics-announces-promising-top-line-results-from-/2023/01/11/9741357.htm"
type: article

provider:
  name: TMCnet
  domain: tmcnet.com

topics:
  - AI in Healthcare
  - AI

secured: "3xEHTA4eij1cHfuX/60pxZl0lEAAUDyZPLi8OokIS0uZmkcaIDXFCOMZCLyFJjaYKw+ldhip4BWhmvE68xYIJZPjgCOHJVVZ9KW4tRITrlH4zeItYW+eTnuX8VCC5p25rO9Aba3PY8fgMJ+BJ9SQQku3eM9LRjdkmVnKpHJkFc9Dt5WLtA+F9WbEegfbOGehGH+YNC4hao6XQkLNO3DDZT5jpX3V8Lcuzno+e8WCyWYOOJjED4zD4j0fdrydmpAprkJQxodybKmKFLi2rgkhSuMnk89zV/chnu9mCSfdID6yVqfdcykbMZqLoXTJnUHLI+QKdegs+PFd6LHtmga++nSq12hrWQT6NV3z59mJcP8=;qCqP9tLPQ4oICwU9UZ5Gow=="
---

